Moreover, VDR being a direct activator of trpv6 promoter [17], and 1,25-dihydroxyvitamin D3 a widely used anticancer treatment have completed an intriguing hypothesis for TRPV6 regulation and significance in prostate cancer. The gene discussed is VDR; the disease is prostate carcinoma.